Meta-Flux, founded in 2021 during the COVID-19 pandemic, is an AI-assisted detection and diagnostics platform focused on disease prevention. By analyzing patterns and fluctuations in personalized medical data, Meta-Flux enables the early identification of diseases with greater accuracy. Leveraging artificial intelligence and advanced software design, the platform significantly reduces the time required to analyze complex health data—cutting processes that traditionally take laboratories several weeks down to much shorter timeframes—helping healthcare providers deliver faster and more effective preventive care.
Meta-Flux
Meta-flux is an AI-driven biology platform for pharmaceutical drug development, using adaptive experimentation and multi-omic data to accelerate discovery, improve disease detection, and support prevention-focused research and clinical testing workflows.



